Oral cyclosporin-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure (Q69235807)
scientific article published on 01 August 1989
Language:
Current Data About Oral cyclosporin-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure
(P31) (Q13442814)
(P248)
(P698) 2507346
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2507346%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 30, 2019

(P304) 136-142
(P248)
(P698) 2507346
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2507346%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 30, 2019

(P433) 2
(P248)
(P698) 2507346
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2507346%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 30, 2019

(P478) 43
(P248)
(P698) 2507346
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2507346%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 30, 2019

(P577) Tuesday, August 1, 1989
(P248)
(P698) 2507346
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2507346%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 30, 2019

(P1433) (Q15765799)
(P248)
(P698) 2507346
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2507346%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 30, 2019

(P1476) "Oral cyclosporin-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure" (language: en)
(P248)
(P698) 2507346
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2507346%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 30, 2019

(P2093) M Hinterberger-Fischer
(P1545) 1
(P248)
(P698) 2507346
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2507346%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 30, 2019

P Höcker
(P1545) 2
(P248)
(P698) 2507346
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2507346%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 30, 2019

K Lechner
(P1545) 3
(P248)
(P698) 2507346
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2507346%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 30, 2019

H Seewann
(P1545) 4
(P248)
(P698) 2507346
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2507346%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 30, 2019

W Hinterberger
(P1545) 5
(P248)
(P698) 2507346
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2507346%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, September 30, 2019

other details
description scientific article published on 01 August 1989

External Links
(P356) 10.1111/J.1600-0609.1989.TB00269.X
(P698) 2507346